Why Illumina Shares Are Plunging Today?
A jury in the U.S. District Court for the District of Delaware rendered a verdict that Illumina Inc (NASDAQ:ILMN) willfully infringed the…
Where Illumina Stands With Analysts
Over the past 3 months, 4 analysts have published their opinion on Illumina (NASDAQ:ILMN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
If You Invested $1000 In Ilumina 10 Years Ago, Here’s How Much You Would Have Today
Illumina (NASDAQ:ILMN) has outperformed the market over the past 10 years by 7.06% on an annualized basis producing an average annual return of 18.79%. Currently, Illumina has a market capitalization of $39.64 billion.
55 Stocks Moving In Friday’s Mid-Day Session
Gainers
Swvl Holdings Corp. (NASDAQ: SWVL) surged 24.4% to $7.50. Swvl Holdings 13D Filing from investor Ahmed Sabbah showed a new 6.4% stake in the company.
Citigroup Maintains Neutral on Illumina, Lowers Price Target to $325
Citigroup analyst Patrick Donnelly maintains Illumina (NASDAQ:ILMN) with a Neutral and lowers the price target from $400 to $325.
Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
FDA Warns Against Relying On Screening Tests For Prenatal Diagnosis
The U.S. FDA is warning that noninvasive prenatal screening (NIPS) tests may provide false results, such as stating a…
Lessons For Elon Musk: 5 Notorious Failed Hostile Takeovers
As any student of industry knows, Elon Musk is hardly the first person to attempt a hostile takeover.